Feel Therapeutics develops Biomarkers and Digital Therapeutics to change the way we diagnose, manage, and care for mental health.
Feel Therapeutics is developing Digital Biomarkers and Therapeutics to bring objective data and measurement in how we diagnose, manage and care for Mental Health.The company is backed by top-tier investors (Felicis, Anthemis, SOSV) and partners with large Pharmaceuticals to develop novel digital biomarkers and bring digital health solutions to market as standalone programs (DTx) or alongside medications (Rx+).Find out more about Feel at www.feeltherapeutics.com or contact us at [email protected]
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 6, 2020 | Series Unknown | $4.20M | 2 | — | — | Detail |
Jan 10, 2019 | Seed | $4.50M | 1 | — | — | Detail |
Dec 20, 2017 | Pre-seed | $1.80M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Sapien Ventures | — | Series Unknown |
Gaingels | — | Series Unknown |
HAX | — | Seed |
Make in LA | — | Pre-seed |